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Summary. HPRTA,~ Arbor is a variant of hypoxanthine (gua- 
nine) phosphoribosyl-transferase (HPRT: EC 2.4.2.8), which 
was identified in two brothers with hyperuricemia and nephro- 
lithiasis. In previous studies, this mutant enzyme was charac- 
terized by an increased Km for both substrates, a normal Vmax, 
a decreased intracellular concentration of enzyme protein, a 
normal suburiit molecular weight and an acidic isoelectric 
point under native isoelectric focusing conditions. We have 
cloned a full-length cDNA for HPRTA~ Arbor and determined 
its complete nucleotide sequence. A single nucleotide change 
(T--~ G) at nucleotide position 396 has been identified. This 
transversion predicts an amino acid substitution from isoleu- 
cine (ATT) to methionine (ATG) in codon 132, which is loca- 
ted within the putative 5'-phosphoribosyl-l-pyrophosphate 
(PRPP)-binding site of HPRT. 
Introduction 
Hypoxanthine-guanine phosphoribosyltransferase (HPRT: 
EC 2.4.2.8) is a purine salvage enzyme that catalyzes the con- 
version of hypoxanthine and guanine to their respective mono- 
nucleotides, IMP and GMP. Complete deficiency of HPRT is 
associated with the Lesch-Nyhan syndrome, an X-linked dis- 
order, which is characterized clinically by hyperuricemia, 
mental retardation, choreoathetosis, and compulsive self- 
mutilation (Seegmiller et al. 1967). Partial deficiency of 
HPRT leads to overproduction of uric acid, which results in 
the development of a severe form of gout and nephrolithiasis 
(Kelley et al. 1967). 
Several mutant forms of HPRT have been isolated from 
patients with gout and the Lesch-Nyhan syndrome. By se- 
quence analysis of tryptic peptides, single amino acid substitu- 
tions have been defined in four HPRT variants (Wilson et al. 
1983). Southern blot analysis has indicated major gene abnor- 
malities in a minority of Lesch-Nyhan patients. These include 
partial and complete deletions and internal duplication of the 
structural gene for HPRT (Yang et al. 1984). More recently, 
ribonuclease A cleavage analysis has been used to localize mu- 
tations at the HPRT locus in five Lesch-Nyhan patients 
(Gibbs and Caskey 1987). 
HPRTAm~ Arbor is a unique structural variant of HPRT, 
which was identified in two brothers, 12 and 14 years old, 
who presented with hyperuricemia and nephrolithiasis. A ma- 
ternal uncle of these patients, who was also partially deficient 
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in HPRT, suffered from a severe form of gout with early on- 
set. In previous studies, HPRTA~ Arbor was shown to have: (i) 
a markedly decreased concentration of enzyme protein, (ii) a 
normal subunit, molecular weight and a more acidic isoelec- 
tric point, (iii) an increased Km for hypoxanthine and 5'-phos- 
phoribosyl-l-pyrophosphate (PRPP) and (iv) a normal Vmax 
(Wilson et al. 1982, 1986). 
The amino acid sequence of this HPRT variant could not 
be determined because the markedly decreased levels of en- 
zyme protein precluded purification of sufficient quantities for 
characterization. In the present study, we have isolated HPRT 
cDNA synthesized from messenger RNA (mRNA) encoding 
HPRTA~ Arbor and have determined its full nucleotide se- 
quence. Using this approach we have identified a single nuc- 
leotide change in codon 132 (ATT--~ATG), which predicts an 
amino acid substitution from isoleucine (Ile) to methionine 
(Met). 
Materials and methods 
AMV reverse transciptase was purchased from Life Science 
and T4 DNA polymerase was from Pharmacia. All other en- 
zymes were purchased from New England Biolabs. Lambda 
gt l l  arms and in vitro packaging extract for lambda DNA 
were obtained from Stratagene. M13 sequencing vectors and 
the universal primer were purchased from Bethesda Research 
Laboratories. [a-32p]dCTP (3000 Ci/mmol), [SsS]dATP (1240 
Ci/mmol) and nitrocellulose filters were obtained from New 
England Nuclear. All other reagents were of the highest qual- 
ity commercially available. 
Construction of  cDNA library 
Ebstein-Barr virus transformed lymphoblast celt lines derived 
from patient K.C. (Wilson et al. 1982) were grown in RPMI 
1640 medium containing 10% fetal calf serum. The lympho- 
blasts were lysed with 6.0 M guanidium isothiocynate and total 
RNA was isolated by ultracentrifugation of the cell lysates in 
5.7M CsC1 (Maniatis et al. 1982). Poly (A)+mRNA was 
purified by oligo-d(T) column chromatography (Aviv and 
Leder 1972) and was electrophoresed in a 0.8% agarose-form- 
aldehyde gel for Northern blot analysis (Fuscoe et al. 1983). 
Oligo-d(T) primed poly (A)+mRNA was reverse trans- 
cribed to synthesize the first cDNA strand. Two methods of 
second strand synthesis were used. In method A, the 
RNA:  cDNA heteroduplex formed during first strand synthe- 
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sis was digested with RNase H and the second strand synthe- 
sized by Escherichia coli DNA polymerase and E. coli DNA 
ligase (Gubler and Hoffman 1983). In method B, after RNase 
H digestion of the first strand heteroduplex, the second strand 
was synthesized by AMV reverse transcriptase (Polites and 
Marotti 1986). The double-stranded cDNA synthesized by 
both methods was blunt-ended with T4 DNA polymerase and 
ligated to Eco RI linkers. After digestion with Eco RI, the 
cDNA was purified by sepharose CL4-B column chromatog- 
raphy and ligated to Eco RI digested lambda gtll  arms 
(Young and Davis 1983) using conditions recommended by 
the supplier. The E. coli (strain Y1088) were infected with re- 
combinant phages. 
Screening of recombinant phages 
Two kinds of probes were used for screening the cDNA lib- 
raries. One was prepared from a 955-base pair (bp) HPRT 
cDNA, which contains the entire HPRT coding sequence 
(kindly provided by C. T. Caskey). The second probe was a 
270-bp Taq I fragment which spans the 5'-noncoding se- 
quences of the HPRT cDNA. Both DNA probes were labeled 
with [c~-3zp]dCTP by the hexadeoxynucleotide priming meth- 
od (Feinberg and Vogelstein 1984). 
Phage plaques (20000 plaques/plate) were transferred to 
nitrocellulose filters and screened by in situ hybridization 
(Benton and Davis 1977). 
Sequence analysis of cDNA 
Recombinant lambda phages derived from single clones were 
grown in E. coli strain Y1088 and purified by centrifugation to 
equilibrium in a CsC1 gradient (Maniatis et al. 1982). Phage 
DNA was digested with Eco RI and subjected to electro- 
phoresis in a 0.8% agarose gel. Eco RI inserts were extracted 
from the gel with DEAE cellulose paper (Dretzen et al. 1981). 
The inserts were then subcloned into the Eco RI site of the 
plasmid vector pUC18. Several fragments of cDNA digested 
with appropriate restriction endonucleases were subcloned 
into the single-stranded phages M13mp18 and M13mp19 for 
sequence analysis. DNA sequencing was carried out by the di- 
deoxynucleotide chain termination method using M13 univer- 
sal primer (Biggin et al. 1983). 
Isoelectric focusing 
Normal lymphoblasts (WI-L2, MGL-8, N333) and lympho- 
blasts from subject KC were lysed by six cycles of freezing and 
thawing. Membrane-free extracts, obtained by centrifugation 
at 100000g for 45 min, were dialyzed in 10mM Tris, pH 7.4, 
with 50 mM NaC1 overnight. 
Isoelectric focusing was performed in polyacrylamide slab 
gels (2ram x 13cm x 16cm) containing 6.0% acrylamide, 
0.16% N, N'-methylene bisacrylamide, 5% glycerol and 5% 
ampholites (pH 5-7, LKB). The gel was prefocused for 2 h 
and samples were loaded by wicking from filters for l h. 
Focusing was complete after an additional 2 h at 10 W. HPRT 
activity was localized by incubation of the gels with substrate 
solution containing 100raM Tris, pH 7.4, 10mM MgC12, 
10mM 5'-phosphoribosyl-l-pyrophosphate (PRPP), and 
72 gM [8-14C]hypoxanthine (45mCi/mmol) for 30min. The 
gel was then blotted with PEI cellulose, which binds IMP but 
not hypoxanthine, washed and exposed to Kodak XAR film 
(Zannis et al. 1980). 
R e s u l t s  
cDNA cloning and sequence analysis 
Messenger RNA encoding HPRTAnn Arbor was indistinguishable 
in its size and amount from mRNA derived from normal lym- 
phoblasts by Northern blot analysis (data not shown). The 
cDNA library synthesized by method A contained approxi- 
mately 5 x 105 recombinant phage plaques. Four plaques from 
this library hybridized to the 950-bp HPRT probe. The sizes 
of the cDNA inserts from these clones were determined by 
Southern blot analysis after Eco RI digestion of phage DNA. 
The largest cDNA from this library was 1.3 kb. This clone was 
designated pHKC1. Method B yielded a library containing ap- 
proximately 4 x 105 recombinants. Of these clones 19 hyb- 
ridized to the 955-bp HPRT cDNA: 8 of these that also hyb- 
ridized to the 270-pb Taq I HPRT probe were selected for in- 
sert sizing. The largest cDNA from this library, 1.45 kb, was 
designated pHKC2. 
The nucleotide sequences of pHKC1 and pHKC2 were de- 
termined as described in Materials and methods. The se- 
quencing strategy employed is diagrammed in Fig. 1. pHKC1 
contained 559 nucleotides of the coding sequence (which is 55 
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Fig. 1. Restriction map and sequencing strategy 
of pHKC1 and pHKC2. The arrows indicate 
directions and the ranges of sequence deter- 
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Fig. 2. A Comparison of the nucleotide sequences of 
normal HPRT and HPRTAnn Arbor. Sequences from base 
position 388 to 405 are shown with the transversion iden- 
tified at position 396. B The amino acid substitution pre- 
dicted by the nucleotide change demonstrated in A. 
(Amino acid 1 is the initial methionine) 
13-mercaptoethanol prior to focusing or by using nondialyzed 
extract instead of a dialyzed one (data not shown). 
Fig. 3. Native polyacrylamide slab gel isoelectric focusing of HPRT. 
The enzyme was detected radiochemically by an in situ activity stain. 
Lymphoblast extracts from normal and mutant cell lines were fo- 
cused. Lane A, WIL-2 (30gg protein); lanes B, E, KC (100gg pro- 
tein); lane C, MGL-8 (30 gg protein); lane D, N333 (30 gg protein) 
nucleotides short of the entire coding sequence), and 592 nuc- 
leotides of the 3' noncoding sequence, pHKC2 contained 119 
nucleotides of 5' noncoding sequence, the entire coding se- 
quence and 592 nucleotides of 3' noncoding sequence. 
A single nucleotide substitution - a T to G transversion at 
nucleotide position 396 - was identified (Fig. 2A). This trans- 
version alters codon 132 (ATT-+ATG)  and predicts an iso- 
leucine to methionine substitution at this position (Fig. 2B). 
This nucleotide change does not alter a restriction recognition 
site within the HPRT gene. The remainder of the sequence, 
including 5'- and 3'-noncoding regions, was identical to nor- 
mal HPRT cDNA (Jolly et al. 1983; Patel et al. 1986). 
Isoelectric focusing 
Dialyzed lymphoblast extract from normal cell lines (WIL-2, 
MGL-8 and N333) demonstrated the same isoelectric focusing 
patterns with three major bands of activity at pH 6.00, pH 
5.90, and pH 5.80 (Fig. 3). HPRT~n  Arbor also showed multi- 
ple bands of activity, but the isoelectric points of this mutant 
enzyme were pH 5.95, pH 5.80, and pH 5.70. These isoelec- 
tric focusing patterns of normal and mutant HPRT did not 
change after treatment of cell extracts with 4.5 M and 0.35 M 
Discussion 
Previous studies have identified structural and functional 
abnormalities of mutant HPRT proteins from erythrocytes, 
fibroblasts, and cultured lymphoblasts derived from HPRT- 
deficient patients with detectable enzyme activity. These 
studies have suggested marked heterogeneity of mutations in 
the structural gene for HPRT (Chinault and Caskey 1984; 
Wilson et al. 1986; Gibbs and Caskey 1987). 
Single amino acid substitutions have been identified in four 
variants from three gouty and one Lesch-Nyhan patient by 
comparative mapping of the tryptic peptides and analysis of 
amino acid sequences (Wilson et al. 1983). Since more than 
two-thirds of HPRT-deficient patients have less than 5% re- 
sidual HPRT immunoreactive protein (Wilson et al. 1986), 
the study of mutations by analysis of residual active protein 
cannot be performed in most HPRT-deficient patients using 
amino acid sequencing techniques. 
Southern blot analysis of genomic DNA derived from 
Lesch-Nyhan patients has demonstrated gross alterations of 
the HPRT gene in a small minority of those studied (Yang et 
al. 1984; Wilsons et al. 1986). These include deletion of the 
entire HPRT gene in one subject, partial gene deletions in two 
subjects, and an internal duplication of exons 2 and 3 in 
another (Yang et al. 1984). Furthermore, 90% of HPRT mu- 
tants have HPRT mRNA of normal size and quantity (Wilson 
et al. 1986). These observations suggest that the majority of 
HPRT mutations are the result of single nucleotide changes or 
small D N A  deletions or rearrangements. 
More recently, ribonuclease A (RNase A) cleavage analy- 
sis has been used to detect small gene abnormalities that can- 
not be identified by Southern blot analysis (Myers et al. 1985; 
Winter et al. 1985; Gibbs and Caskey 1987). Gibbs and Cas- 
key (1987) localized the putative sites of mutations in HPRT 
mRNA of five Lesch-Nyhan patients using this technique. 
This technique can reveal abnormalities in less than half of 
HPRT-deficient subjects because of the failure of RNase A to 
recognize and cleave certain mismatches in R N A : R N A  or 
R N A : D N A  hybrids (Myers et al. 1985; Winter et al. 1985; 
Gibbs and Caskey 1987). Furthermore, while this analysis can 
localize mutations in HPRT mRNA,  it cannot be used to de- 
42 
termine the exact nucleotide changes except when alMe-spe- 
cific oligonucleotides (ASO) are available that allow deduc- 
tion of certain nucleotide substitutions (Caskey 1987). In gen- 
eral, however, construction of an ASO requires prior knowl- 
edge of the mutation itself. 
Cloning mutant forms of HPRT D N A  sequences is a logi- 
cal approach to the detection, localization, and characteriza- 
tion of mutations at the nucleotide level. Since the human 
HPRT gene is large (approximately 44 kb) and complex (eight 
introns; Patel et al. 1986), genomic cloning is impractical in 
most cases. Therefore, in cases where sufficient mRNA is pre- 
sent, mutant cDNA cloning is the method of choice. 
In this study, we have isolated the cDNA encoding 
HPRTAr~ Arbor- Comparison of the primary structures of six 
phosphoribosyltransferase (HPRTases) that use as a substrate 
has revealed considerable amino acid sequence homology 
with positions 129-141 in the human HPRT protein. This 
highly conserved region is probably a part of the PRPP bind- 
ing site (Hershey and Taylor 1986). The mutation in HPRTA~n 
A~bor falls within this region and offers an explanation for the 
altered kinetic parameters of this mutant enzyme. Addition- 
ally, human HPRT protein has a [3a[~ secondary structure in 
residues 1 to 120, which is characteristic of a nucleotide-bind- 
ing fold. This type of structure has also been implicated in 
PRPP binding (Argos et al. 1983). 
In previous kinetic studies of HPRTAn~ Arbo, this mutant 
enzyme exhibited a normal Vmax, a 2-fold-increased Km for 
PRPP and a 10-fold increased Km for hypoxanthine (Wilson et 
al. 1986). Thus, the Ile to Met substitution at 132 appears to 
exert an effect on the binding of both substrates without alter- 
ing the catalytic activity of the enzyme. HPRTMunioh (Ser---~ 
Argl03) and HPRTLondon (Ser--~ Leu109) have an increased 
Km for hypoxanthine and a normal Km for PRPP (Wilson et al. 
1983). The region between residues 60-114 has been sus- 
pected to contribute to the formation of the hypoxanthine- 
binding site (Argos et al. 1983; Hershey and Taylor 1986). 
However, the mutation in HPRTAn~ Arbor is far from the puta- 
tive hypoxanthine-binding site, and is located within the puta- 
tive PRPP-binding site proposed by Hershey and Taylor 
(1986). 
We can propose two hypotheses to explain the increased 
Km for hypoxanthine in HPRTAn~ Arbor. First, secondary struc- 
tural change at residue 132 may have a marked effect on the 
folding of the protein resulting in a change of the tertiary or 
quartenary structure with reduction in affinity for hypoxan- 
thine. Second, human HPRT catalyzes the formation of IMP 
predominantly through an ordered BiBi kinetic mechanism 
with PRPP serving as the first substrate (Giacomello and 
Salermo 1978). A mutation within the PRPP binding site may 
thus affect the formation of PRPP - enzyme complex result- 
ing in alteration of affinity for hypoxanthine. 
HPRTAnn Arbor from lymphoblasts was previously shown to 
have one immunoreactive isoelectric species with a more 
acidic isoelectric point compared to the normal enzyme (Wil- 
son et al. 1982). Several investigators reported that HPRT 
from lymphoblasts has one isoelectric point, while enzyme 
from erythrocytes has multiple isoelectric points, resulting 
from extensive post-translational modification (Ghancas and 
Milman 1977; Johnson et al. 1982; Wilson et al. 1982). In this 
study, we used a narrower pH range (pH 5-7) than was used 
in previous reports (pH 3.5-10). Under these conditions, lym- 
phoblast HPRT also has multiple isoelectric points. Addition- 
ally, treatment with 4.5 M urea did not change the isoelectric 
focusing pattern for the normal or mutant protein suggesting 
that the pattern is not a result of binding of small molecules by 
the enzyme (Zannis et al. 1980). 
The concentrations of HPRT protein applied to the gel 
were 150-50011g/ml. At  these concentrations, the enzyme 
electrofocuses as a dimer (Johnson et al. 1979). Therefore, 
lymphoblast HPRT appears to be composed of two major 
types of subunits with different isoelectric points. These find- 
ings suggest that HPRT from lymphoblast cell lines also un- 
dergoes post-translational modification. 
The predicted amino acid substitution in HPRTA~n Arbor is 
neutral with respect to charge. Thus, its variant isoelectric 
points cannot be explained by a charge difference between 
isoleucine and methionine. The small magnitude of the pI 
shifts in HPRTAnn Arbor suggest that the substitution alters the 
environment of other ionizable groups resulting in minor 
changes in their pKs. Alternatively, the amino acid substitu- 
tion may affect one of the several post-translational modifica- 
tions the enzyme undergoes. 
Since the amount of mRNA encoding HPRTAnn Arbor is not 
decreased in the cell, the decreased intracellular concentra- 
tion of the enzyme may be caused by either the dysfunction of 
mRNA (decreased synthesis of protein) or the instability of 
the translation product (accelerated degradation of protein). 
A complete understanding of the relationship between the 
single nucleotide change and the decreased intracellular en- 
zyme concentration will require additional studies, such as in 
vitro translation and in vivo turnover of the enzyme. 
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